<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kim AL</submitter><funding>the Ministry of SMEs and Startups</funding><funding>the Rural Development Administration (RDA)</funding><funding>the National Research Foundation (NRF)</funding><funding>the Ministry of Trade, Industry and Energy</funding><pagination>3088</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9697443</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(22)</volume><pubmed_abstract>&lt;i>Cannabis&lt;/i> (&lt;i>Cannabis sativa&lt;/i> L.) is widely cultivated and studied for its psychoactive and medicinal properties. As the major cannabinoids are present in acidic forms in &lt;i>Cannabis&lt;/i> plants, non-enzymatic processes, such as decarboxylation, are crucial for their conversion to neutral active cannabinoid forms. Herein, we detected the levels of cannabidivarin (CBDV), cannabidiol (CBD), cannabichromene (CBC), and Δ9-tetrahydrocannabinol (Δ9-THC) in the leaves and vegetative shoots of five commercial &lt;i>Cannabis&lt;/i> cultivars using a combination of relatively simple extraction, decarboxylation, and high-performance liquid chromatography analyses. The CBDV, CBC, and Δ9-THC levels were 6.3-114.9, 34.4-187.2, and 57.6-407.4 μg/g, respectively, and the CBD levels were the highest, ra</pubmed_abstract><journal>Plants (Basel, Switzerland)</journal><pubmed_title>Profiling Cannabinoid Contents and Expression Levels of Corresponding Biosynthetic Genes in Commercial &lt;i>Cannabis&lt;/i> (&lt;i>Cannabis sativa&lt;/i> L.) Cultivars.</pubmed_title><pmcid>PMC9697443</pmcid><funding_grant_id>2020R1I1A1A01072914</funding_grant_id><funding_grant_id>PJ01652303</funding_grant_id><funding_grant_id>20012892</funding_grant_id><funding_grant_id>1425151434</funding_grant_id><pubmed_authors>Choi HW</pubmed_authors><pubmed_authors>Kim AL</pubmed_authors><pubmed_authors>Yun YJ</pubmed_authors><pubmed_authors>Hong CH</pubmed_authors><pubmed_authors>Kim YC</pubmed_authors><pubmed_authors>Shim HJ</pubmed_authors><pubmed_authors>Lee JH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Profiling Cannabinoid Contents and Expression Levels of Corresponding Biosynthetic Genes in Commercial &lt;i>Cannabis&lt;/i> (&lt;i>Cannabis sativa&lt;/i> L.) Cultivars.</name><description>&lt;i>Cannabis&lt;/i> (&lt;i>Cannabis sativa&lt;/i> L.) is widely cultivated and studied for its psychoactive and medicinal properties. As the major cannabinoids are present in acidic forms in &lt;i>Cannabis&lt;/i> plants, non-enzymatic processes, such as decarboxylation, are crucial for their conversion to neutral active cannabinoid forms. Herein, we detected the levels of cannabidivarin (CBDV), cannabidiol (CBD), cannabichromene (CBC), and Δ9-tetrahydrocannabinol (Δ9-THC) in the leaves and vegetative shoots of five commercial &lt;i>Cannabis&lt;/i> cultivars using a combination of relatively simple extraction, decarboxylation, and high-performance liquid chromatography analyses. The CBDV, CBC, and Δ9-THC levels were 6.3-114.9, 34.4-187.2, and 57.6-407.4 μg/g, respectively, and the CBD levels were the highest, ra</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2026-06-21T03:11:27.281Z</modification><creation>2025-04-06T23:22:31.476Z</creation></dates><accession>S-EPMC9697443</accession><cross_references><pubmed>36432817</pubmed><doi>10.3390/plants11223088</doi></cross_references></HashMap>